Literature DB >> 19083544

New neurotoxins on the horizon.

Scott R Freeman1, Joel L Cohen.   

Abstract

Toxins isolated from lethal bacteria allow for safe, versatile, and minimally invasive interventions that have revolutionized the field of cosmetic and therapeutic treatments. Botulinum toxins are high-molecular weight proteins produced by Gram-positive, spore-forming Clostridial bacteria. The toxins of 5 distinct strains (A, B, E, F, and G) affect humans. Currently, type A and B toxins are available for the treatment of human diseases in the United States, with type A being the only agent approved for cosmetic use by the U.S. Food and Drug Administration. This article reviews the history of botulinum toxin as a cosmetic intervention, discusses its current role in cosmetic treatment, and provides an update of other neurotoxins on the horizon for therapeutic and cosmetic use.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19083544     DOI: 10.1016/j.asj.2008.03.006

Source DB:  PubMed          Journal:  Aesthet Surg J        ISSN: 1090-820X            Impact factor:   4.283


  3 in total

Review 1.  [New botulinum toxins for aesthetic dermatology : A comprehensive review].

Authors:  A Patil; M Kassir; U Wollina; M Goldust
Journal:  Hautarzt       Date:  2021-04-06       Impact factor: 0.751

Review 2.  Overview of Facial Plastic Surgery and Current Developments.

Authors:  Jessica Chuang; Christian Barnes; Brian J F Wong
Journal:  Surg J (N Y)       Date:  2016-02-04

Review 3.  FDA Approvals and Consensus Guidelines for Botulinum Toxins in the Treatment of Dystonia.

Authors:  Lauren L Spiegel; Jill L Ostrem; Ian O Bledsoe
Journal:  Toxins (Basel)       Date:  2020-05-17       Impact factor: 4.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.